Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-21-010371
Filing Date
2021-08-24
Accepted
2021-08-24 16:30:06
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 30913
2 filename2.txt TEXT-EXTRACT 6276
  Complete submission text file 0000000000-21-010371.txt   49692
Mailing Address 279 E. GRAND AVENUE, SUITE 300, LOBBY B SOUTH SAN FRANCISCO CA 94080
Business Address 279 E. GRAND AVENUE, SUITE 300, LOBBY B SOUTH SAN FRANCISCO CA 94080 650-566-1402
DICE Therapeutics, Inc. (Filed for) CIK: 0001645569 (see all company filings)

EIN.: 472286244 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD
SIC: 2834 Pharmaceutical Preparations